Unlocking Opportunities in the Gastrointestinal Stromal Tumor Market: Key Trends, Market Growth, and Forecast Insights
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Drivers Are Shaping the Growth and Development of theGastrointestinal Stromal Tumor Market?
The surge in stomach cancer cases is projected to spur the expansion of the market for gastrointestinal stromal tumors. Stomach cancer involves the malignant, uncontrolled growth of cells in the stomach lining. Although gastrointestinal stromal tumors (GISTs) can manifest in the stomach, they are different from stomach cancer. Patients with GISTs have a higher likelihood of developing additional cancers like small bowel adenocarcinoma when two distinct tumors combine into one. As noted by the American Cancer Society, come January 2024, approximately 26,890 new instances of stomach cancer and 10,880 deaths are expected in the U.S. for 2024, making up 1.5% of all fresh cancer diagnoses. As such, the escalating occurrence of stomach cancer is bolstering the expansion of the gastrointestinal stromal tumor market. The increasing need for precision medicine is forecasted to fuel the advancement of the gastrointestinal stromal tumor market. Precision medicine offers a tailored healthcare approach that factors in the individual characteristics of patients, such as their genetic makeup and lifestyle, when formulating decisions, interventions, and therapies. Precision medicine applied to gastrointestinal stromal tumors employs molecular profiling to uncover specific mutations and direct targeted therapies such as imatinib. This enhances the efficacy of treatments and diminishes side effects through personalized interventions. As per a report issued in February 2023 by the Personalized Medicine Coalition (PMC), a nonprofit organization based in the US, personalized medicines made up 35% of all newly authorized NMEs in 2021. Despite attaining 12 new approvals in 2022, they have consistently held a share of at least a quarter of all new drug approvals in the last eight years, up from less than 10% ten years prior. As a result, the growing demand for precision medicine is driving the advancement of the gastrointestinal stromal tumor market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13248&type=smp
#What is the Growth Potential of the Gastrointestinal Stromal Tumor Market, and How Will It Perform by 2034?
The market size of gastrointestinal stromal tumors has seen significant growth in recent years. Projected expansion is set from $1.28 billion in 2024 to $1.37 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. This growth during the historic period is linked to amplified awareness and early detection, the advent of specialized treatments, better surgical methods, the emergence of individualized medicine, and improvements in supportive care.
In the coming years, the market for gastrointestinal stromal tumors is predicted to experience robust growth. The market valuation is anticipated to reach $1.82 billion by the year 2029, displaying a compound annual growth rate (CAGR) of 7.4%. The progress expected over the forecast period is on account of factors such as sustained research and development of drugs, an increase in patient-centered healthcare, ongoing integration of precision medicine into clinics, enhanced accessibility to targeted therapies, and the growth of genomic profiling capabilities. The forecast period will also see notable trends like an increased collaboration in R&D, improvements in diagnostic technology, joint research and clinical tests, greater emphasis on early detection and diagnosis, and investigation into the use of combinatory therapies.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13248
Which Cutting-Edge Market Trends Are Expected to Drive theGastrointestinal Stromal Tumor Market’s Growth?
Leading corporations in the gastrointestinal stromal tumor market are developing innovative drugs like QINLOCK (Ripretinib) to cater to a wider customer base, boost sales, and augment revenue. QINLOCK (Ripretinib) is a prescribed medication for the treatment of advanced gastrointestinal stromal tumor (GIST). For example, the US Food and Drug Administration (FDA), a federal institution based in the US, recorded that the number of novel drug approvals by the CDER surged from 37 in 2022 to 55 in 2023. Notably, out of the 55 new drugs approved in 2023, CDER categorized 20 (36%) as first-in-class.
What Are the Leading Market Players Impacting theGastrointestinal Stromal Tumor Market’s Growth Trend?
Major companies operating in the gastrointestinal stromal tumor market report are Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck & Co. Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca PLC, Eli Lilly and Company, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., NATCO Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Boston Biomedical Inc., DNAtrix Inc., Advenchen Laboratories LLC, Arog Pharmaceuticals Inc., AB Sciences S.A.
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the Gastrointestinal Stromal Tumor Market Driving Opportunities and Innovations?
The gastrointestinal stromal tumor market covered in this report is segmented –
1) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types
2) By Indication: Stomach, Small Intestine, Others Indications
3) By End-User: Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users
Subsegments:
1) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy Regimens
2) By Targeted Therapy: Tyrosine Kinase Inhibitors, Other Targeted Agents
3) By Other Treatment Types: Surgery, Radiation Therapy, Clinical Trials For Novel Therapies
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13248&type=smp
What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theGastrointestinal Stromal Tumor Market?# Market Expansion?
North America was the largest region in the gastrointestinal stromal tumor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal stromal tumor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global Gastrointestinal Stromal Tumor Market 2025, By The Business Research Company:
Intratumoral Cancer Therapies Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intratumoral-cancer-therapies-global-market-report
Solid Tumor Cancer Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/solid-tumor-cancer-treatment-global-market-report
Circulating Tumor Cells Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
